Table 3. Distribution of IDH1 mutations in glioma patients based on sequencing results.
| WHO Grade | Wild-type | Mutant | Total | Positive Rate | Significance |
|---|---|---|---|---|---|
| II | 10 | 10 | 20 | 50.00% | 0.043 |
| III | 22 | 8 | 30 | 26.67% | |
| IV | 11 | 1 | 12 | 8.33% | |
| Total | 43 | 19 | 62 | 30.65% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.